Vertex Pharmaceuticals (VRTX) EPS (2009 - 2026)
Vertex Pharmaceuticals (VRTX) EPS from Dec 31, 2009 to Mar 31, 2026. The TTM Vertex Pharmaceuticals (VRTX) EPS is $17.04. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Vertex Pharmaceuticals (VRTX) EPS CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | +10.31% |
| 5 Years TTM | +9.89% |
Annual EPS change of Vertex Pharmaceuticals (VRTX)
| Year | EPS | Change |
|---|---|---|
| 2026 | $4.06 | -73.93% |
| 2025 | $15.56 | -846.66% |
| 2024 | -$2.08 | -114.84% |
| 2023 | $14.05 | +8.67% |
| 2022 | $12.93 | +40.44% |
| 2021 | $9.20 | -11.79% |
| 2020 | $10.43 | +129.64% |
| 2019 | $4.54 | -44.71% |
| 2018 | $8.22 | +689.86% |
| 2017 | $1.04 | -330.55% |
| 2016 | -$0.45 | -80.02% |
| 2015 | -$2.26 | -26.06% |
| 2014 | -$3.05 | +60.48% |
| 2013 | -$1.90 | +286.45% |
| 2012 | -$0.49 | -448.66% |
| 2011 | $0.14 | -103.81% |
| 2010 | -$3.71 | +15.45% |
| 2009 | -$3.21 | N/A |
Comparison Vertex Pharmaceuticals (VRTX) five years EPS CAGR with competitors
Vertex Pharmaceuticals (VRTX) five years EPS CAGR is 9.89%.